CCL2 and neoplasm: In contrast to this explanation, Peng et al. showed that neutralizing MCP-1, secreted by the MCA-205 sarcoma, improved the therapeutic efficacy of tumor-specific effector T cells in mediating regression of established pulmonary metastases [48].